HLB Pharmaceutical Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2019	FY 2018	FY 2017
Period Ending	Dec '19 Dec 31, 2019	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017
Cash & Equivalents	2,744	2,744	3,030	5,350
Short-Term Investments	1,310	1,310	235	525
Trading Asset Securities	11,109	11,109	5,842	5,514
Cash & Short-Term Investments	15,163	15,163	9,107	11,389
Cash Growth	66.50%	66.50%	-20.04%	-
Accounts Receivable	7,910	7,910	6,044	6,382
Other Receivables	156.15	156.15	163.97	128.86
Receivables	8,066	8,066	6,218	6,521
Inventory	5,648	5,648	5,382	4,884
Prepaid Expenses	47.26	47.26	428.26	242.13
Other Current Assets	93.85	93.85	140.41	230.82
Total Current Assets	29,018	29,018	21,275	23,267
Property, Plant & Equipment	15,315	15,315	13,304	13,323
Long-Term Investments	146.5	146.5	1,265	1,789
Other Intangible Assets	446.2	446.2	282.13	188.45
Long-Term Deferred Tax Assets	208.27	208.27	6.99	1,002
Long-Term Deferred Charges	629.76	629.76	129.67	-
Other Long-Term Assets	82.12	82.12	160.27	277.32
Total Assets	45,846	45,846	36,423	39,846
Accounts Payable	2,404	2,404	4,856	2,261
Accrued Expenses	4,593	4,593	2,092	2,241
Short-Term Debt	8,458	8,458	4,854	1,725
Current Portion of Long-Term Debt	780	780	1,580	10,388
Current Portion of Leases	426.67	426.67	-	-
Current Income Taxes Payable	-	-	105.9	-
Other Current Liabilities	6,429	6,429	2,736	1,126
Total Current Liabilities	23,092	23,092	16,224	17,741
Long-Term Debt	1,580	1,580	1,260	2,840
Long-Term Leases	1,954	1,954	-	-
Long-Term Deferred Tax Liabilities	-	-	314.93	-
Other Long-Term Liabilities	151.41	151.41	105.72	88.99
Total Liabilities	27,943	27,943	19,425	23,045
Common Stock	6,924	6,924	6,924	6,247
Additional Paid-In Capital	8,435	8,435	17,304	15,263
Retained Earnings	1,215	1,215	-8,453	-5,410
Treasury Stock	-5.6	-5.6	-5.6	-5.6
Comprensive Income & Other	1,334	1,334	1,229	707.13
Shareholders' Equity	17,903	17,903	16,998	16,802
Total Liabilities & Equity	45,846	45,846	36,423	39,846
Total Debt	13,198	13,198	7,694	14,953
Net Cash (Debt)	1,965	1,965	1,413	-3,564
Net Cash Growth	39.05%	39.05%	-	-
Net Cash Per Share	141.88	141.88	104.39	-297.72
Filing Date Shares Outstanding	13.85	13.85	13.85	12.49
Total Common Shares Outstanding	13.85	13.85	13.85	12.49
Working Capital	5,927	5,927	5,052	5,526
Book Value Per Share	1292.83	1292.83	1227.52	1344.92
Tangible Book Value	17,457	17,457	16,716	16,613
Tangible Book Value Per Share	1260.61	1260.61	1207.15	1329.84
Land	1,239	1,239	1,239	1,239
Buildings	8,520	8,520	8,472	8,581
Machinery	9,673	9,673	8,772	9,892
Construction In Progress	382.9	382.9	183.6	136.94

Source: S&P Capital IQ. Standard template. Financial Sources.